Methylphenidate (MPH) is the most common first-line therapy for ADHD in Europe 1.
Many studies have examined its effectiveness and have shown a response rate of around …

Introduction The Comparison of Methylphenidate and Psychotherapy in adult ADHD Study
(COMPAS) was a prospective, randomized multicenter clinical trial, comparing …

We have read with interest the article by Pauly et al.[1], describing the use of
methylphenidate and coprescribed psychotropic medications in children and adults in a four …

Introduction Attention-deficit/hyperactivity disorder (ADHD) affects many adults who had
ADHD in childhood. Although stimulants and methylphenidate in particular are a common off …

Attention-deficit/hyperactivity disorder (ADHD) is a highly prevalent mental disorder of
childhood, which often persists in adulthood. Methylphenidate (MPH) is one of the most …

Objective Off-label prescription is a common practice in psychiatry, raising health and
economic concerns. Collegial consultation could allow a framed prescription of treatments …

Abstract Patients with Attention Deficit/Hyperactivity Disorder (ADHD) and comorbid
Substance Use Disorders (SUD) are increasingly being treated with central stimulant …

Background Despite a decreasing population of children and adolescents, the cumulative
total amount of dispensed methylphenidate (MPH), the first-choice treatment of attention …

Objectives We will present results of a systematic review of the effectiveness of
methylphenidate in the treatment of adult ADHD. Furthermore, we will discuss the influence …

Attention-deficit hyperactivity disorder (ADHD) is associated with substantial personal and
social impairments. Besides psychosocial interventions, current guidelines recommend a …